Not available
Quote | Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Last: | $14.53 |
---|---|
Change Percent: | 0.0% |
Open: | $13.84 |
Close: | $14.53 |
High: | $14.55 |
Low: | $13.822 |
Volume: | 457,187 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Avadel Pharmaceuticals plc (NASDAQ:AVDL)
2024-06-27 16:11:21 ET More on Avadel Pharmaceuticals plc Avadel Pharmaceuticals: Inflection Point Ahead Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug...
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Ind...
Message Board Posts | Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Subject | By | Source | When |
---|---|---|---|
Price gaining up | Triple nickle | investorshub | 06/19/2023 10:24:46 AM |
The gaining | ClayTrader | investorshub | 06/19/2023 7:36:18 AM |
$AVDL Price gaining | TheFinalCD | investorshub | 06/19/2023 5:10:18 AM |
$AVDL Have a look at this | Triple nickle | investorshub | 06/18/2023 1:38:08 AM |
Price now up | ClayTrader | investorshub | 06/17/2023 12:07:20 AM |
News, Short Squeeze, Breakout and More Instantly...
Avadel Pharmaceuticals plc Company Name:
AVDL Stock Symbol:
NASDAQ Market:
Avadel Pharmaceuticals plc Website:
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Ind...
2024-05-29 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in narcolepsy care – DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -...